Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.42 |
| ▸ | TUBB | P07437 | 1/20 | 0.42 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.42 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.42 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.42 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.42 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.42 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.42 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.42 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.42 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.42 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.42 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.42 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532602 | 1.00 | TRPA1 (0.48) | TRPA1MAOBNFE2L2MEN1KMT2A | |
| SCHEMBL3320434 | 0.83 | CYP1A2 (0.46) | TRPA1MAOBMEN1KMT2ACYP1A2 | |
| SCHEMBL3320431 | 0.83 | CYP1A2 (0.46) | TRPA1MAOBMEN1KMT2ACYP1A2 | |
| SCHEMBL2782387 | 0.83 | TDP1 (0.47) | MAOBMEN1KMT2ACYP1A2CYP1B1 | |
| SCHEMBL9491145 | 0.82 | MEN1 (0.65) | TRPA1NFE2L2MEN1KMT2AKDM4E | |
| SCHEMBL9493051 | 0.80 | MEN1 (0.41) | TRPA1MEN1KMT2ACYP1A2KDM4E | |
| SCHEMBL12066326 | 0.80 | TRPA1 (0.52) | TRPA1MAOBNFE2L2MEN1KMT2A | |
| SCHEMBL11539633 | 0.80 | TRPA1 (0.52) | TRPA1MAOBNFE2L2MEN1KMT2A | |
| SCHEMBL17580726 | 0.78 | TRPA1 (0.45) | TRPA1MAOBNFE2L2MEN1KMT2A | |
| SCHEMBL17580727 | 0.78 | TRPA1 (0.45) | TRPA1MAOBNFE2L2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-117843528-A | Treatment method of waste liquid in electrochemical adiponitrile production | 万华化学集团股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117138097-A | Drug-loaded embolism gel microsphere, preparation method thereof and drug-loaded embolism gel microsphere | 湖南埃普特医疗器械有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-115380993-B | Clathrate compound containing baohuoside I, composition, preparation method and application thereof | 四川合泰新光生物科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| CN-115380993-A | Clathrate compound containing baohuoside I, composition, preparation method and application thereof | 四川合泰新光生物科技有限公司 | 2022-11-25 | — | — | CN | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| US-11069856-B2 | Solution for organic EL, method of producing organic EL device and organic EL device | JOLED INC. (JP) | 2021-07-20 | — | — | US | claimed |
| CN-110358629-B | Aroma-carrying nano particle with photo-thermal response controlled release capability and preparation method thereof | 浙江大学 | 2021-05-04 | — | — | CN | claimed |
| US-5626852-A | HYDROLYSIS OF ACETAL AND/OR KETAL | THE MENNEN COMPANY (US) | 1997-05-06 | — | — | US | claimed |
| EP-0625905-A4 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE. | MENNEN CO (US) | 1997-02-26 | — | — | EP | claimed |
| EP-0625905-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-11-30 | — | — | EP | claimed |
| WO-1994006441-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-03-31 | — | — | WO | claimed |
| US-4360606-A | Photo-degradable polymer compositions | OWENS-ILLINOIS, INC. (US) | 1982-11-23 | — | — | US | claimed |
| US-4101720-A | Degradable plastic | OWENS-ILLINOIS, INC. (US) | 1978-07-18 | — | — | US | claimed |
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-16 | — | — | US | disclosed |
| US-4036886-A | FROM A PHENYL ALKENYL BROMIDE AND LITHIUM SALT OF A SCHIFF BASE OF ACETALDEHYDE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-4031140-A | FLAVORS, ODORS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | CUTA, SHBG, DSG1 | TRPA1 41/4885MAOB 4455/4885NFE2L2 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.